# Real-world Dapagliflozin Experience in Patients With Heart Failure in United Kingdom.

> **NCT05188144** · — · COMPLETED · sponsor: **AstraZeneca** · enrollment: 237 (actual)

## Conditions studied

- Heart Failure

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT05188144
- **Lead sponsor:** AstraZeneca
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2021-11-29
- **Primary completion:** 2024-03-02
- **Final completion:** 2024-03-02
- **Target enrollment:** 237 (ACTUAL)
- **Last updated:** 2025-02-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05188144

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05188144, "Real-world Dapagliflozin Experience in Patients With Heart Failure in United Kingdom.". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT05188144. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*